| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.29582 |
| P698 | PubMed publication ID | 29023812 |
| P2093 | author name string | Claire Francoz | |
| Jacques Belghiti | |||
| Valérie Paradis | |||
| Olivier Soubrane | |||
| François Cauchy | |||
| Maxime Ronot | |||
| Béatrice Aussilhou | |||
| Louise Barbier | |||
| Prof Valérie Vilgrain | |||
| P2860 | cites work | Autosomal dominant polycystic kidney disease | Q55898854 |
| Inferior vena caval compression by hepatic cysts: an unusual complication of adult polycystic kidney disease | Q68694853 | ||
| Budd-Chiari syndrome in autosomal dominant polycystic kidney disease: a complication of nephrectomy in patients with liver cysts | Q70555096 | ||
| Adult polycystic liver disease: is fenestration the most adequate operation for long-term management? | Q73132254 | ||
| The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy | Q81573118 | ||
| Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation | Q82971663 | ||
| Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma | Q83202934 | ||
| Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases | Q28576110 | ||
| Outcomes and Durability of Hepatic Reduction after Combined Partial Hepatectomy and Cyst Fenestration for Massive Polycystic Liver Disease | Q28595645 | ||
| A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 | ||
| Hepatic venous outflow obstruction: three similar syndromes | Q34099434 | ||
| Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease | Q34220059 | ||
| Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment | Q34407526 | ||
| Cholangitis and Budd Chiari syndrome as complications of simple cystic liver disease | Q36743105 | ||
| Medical and surgical treatment options for polycystic liver disease1 | Q37812060 | ||
| Diagnosis and management of polycystic liver disease | Q38072284 | ||
| The significance of nonobstructive sinusoidal dilatation of the liver: Impaired portal perfusion or inflammatory reaction syndrome | Q38356626 | ||
| Extended liver resection for polycystic liver disease can challenge liver transplantation. | Q39277652 | ||
| Acute extrahepatic infectious or inflammatory diseases are a cause of transient mosaic pattern on CT and MR imaging related to sinusoidal dilatation of the liver | Q40891444 | ||
| Somatostatin analogues reduce liver volume in polycystic liver disease | Q46417370 | ||
| Imaging findings of hepatic sinusoidal dilatation. | Q53609961 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | polycystic liver disease | Q246002 |
| P577 | publication date | 2017-10-10 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Polycystic liver disease: Hepatic venous outflow obstruction lesions of the non-cystic parenchyma have major consequences |
Search more.